Flindt-Hansen H, Tikjøb G, Brandrup F.
DOI: 10.2340/0001555564177179

In order to investigate the efficacy of anthralin (Anthraderm ) in the treatment of warts a randomized controlled trial was carried out in 72 patients. During a two-month period of treatment 56% were cured in the group treated with anthralin 2% (Anthraderm ), evaluated at follow-up 2-9 months after finishing treatment, compared with 26% in the group treated with the comparative drug (Verucid ). Anthralin 2% (Anthraderm ) was found to have a significantly better effect, especially in the group of patients with warts solely on the hands